• Nenhum resultado encontrado

Rev. Saúde Pública vol.50 suppl.2 rsp s2 S01518

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Saúde Pública vol.50 suppl.2 rsp s2 S01518"

Copied!
12
0
0

Texto

Loading

Imagem

Table 1. Sociodemographic and health profile of older adults by age group a . PNAUM, Brazil, 2014
Table 2 analyzes the prevalence of chronic-use medicines for the eight chronic diseases, among  the older adults who reported at least one of those diseases (74%), according to sociodemographic  and health variables
Table 2. Prevalence of older adults that utilize chronic-use medicines (CM) for at least one of the eight chronic diseases, according to  sociodemographic and health variables
Table 3. Multivariate model for risk factors for polypharmacy among older adults with at least one of  the eight chronic diseases.
+2

Referências

Documentos relacionados

Of all the medicines reported for use in high blood pressure, group 1 (medicines deinitely used to treat high blood pressure) corresponded to 90.5%, group 2 (drugs associated with

The Secretariat of Science, Technology and Strategic Inputs of the Brazilian Ministry of Health commissioned from research institutions of different Brazilian state

he highest prevalence of low adherence was associated with individuals: young adults; no education; resident in the Northeast and Midwest Regions of Brazil; paying part of

he sources for obtaining the generic medicines (pharmacy of SUS – public network, private pharmacy, pharmacy from the Farmácia Popular program [Popular Pharmacy Program], and

he PNAUM survey was the irst national study in Brazil that was speciically designed to evaluate medicines use in the ive geographic regions of Brazil, which resulted in detailed

his fact could also explain the positive association between the practice of self-medication with the various regions in Brazil and among individuals with chronic diseases

prevalence of certain chronic diseases among American children aged ive to 19, children are most commonly afected by acute medical conditions, directly inluencing how drugs are

As methodological strategy, we analyzed the free access to the treatment of chronic diseases in those who reported full access to treatment, analyzing the socioeconomic